DOI:
10.1055/s-00000125
Senologie - Zeitschrift für Mammadiagnostik und -therapie
LinksClose Window
References
NCRI.
UK clinical guidelines for the use of adjuvant trastuzumab (Herceptin®) with or following chemotherapy in HER2-positive early breast cancer.
London (UK):
NCRI; 2005
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.